Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-23T19:45:39.176Z Has data issue: false hasContentIssue false
  • English
  • Français

Rising incidence of head and neck mucosal melanoma in Australia

Published online by Cambridge University Press:  05 December 2016

D Youssef ,
S Vasani ,
J Marquess  and
A Cervin
D Youssef*
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital
S Vasani
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital
J Marquess
Affiliation:
Queensland Department of Health, Communicable Diseases Unit, Herston
A Cervin
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital School of Medicine, University of Queensland, Brisbane, Australia
*
Address for correspondence: Dr Daniel Youssef, Department of Otolaryngology, Head and Neck Surgery, Royal Brisbane and Women's Hospital, Herston, Queensland 4006, Australia E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To establish Australian population-based incidence trends for mucosal melanoma of the head and neck.

Methods:

Cases between 1985 and 2009 were identified in the Australian Cancer Database. Age-standardised incidence trends were established, including subgroup stratification by sex and site.

Results:

A continuously progressive increase in incidence was evident in the 353 cases identified over the 25-year study period. This was particularly evident in sinonasal mucosal melanoma in men, despite the overall incidence remaining higher in women.

Conclusion:

There is such paucity in published global incidence trends of head and neck mucosal melanoma. Comparisons of incidence patterns between countries can provide insight into aetiological factors of this rare disease.

Keywords

Malignant MelanomaNasal MucosaIncidenceAustralia
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 131 , Supplement S2: ASOHNS Supplement , July 2017 , pp. S25 - S28
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the Australian Society of Head and Neck Surgery Annual Scientific Meeting, 7–9 March 2015, Sydney, Australia.

References

1 Simard, EP, Ward, EM, Siegel, R, Jemal, A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin 2012;62:118–28Google Scholar
2 Jangard, M, Hansson, J, Ragnarsson-Olding, B. Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960–2000. Rhinology 2013;51:22–30 Google Scholar
3 Cagir, B, Whiteford, MH, Topham, A, Rakinic, J, Fry, RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum 1999;42:1203–8Google Scholar
4 Coté, TR, Sobin, LH. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin. Melanoma Res 2009;19:58–60 Google Scholar
5 Marcus, DM, Marcus, RP, Prabhu, RS, Owonikoko, TK, Lawson, DH, Switchenko, J et al. Rising incidence of mucosal melanoma of the head and neck in the United States. J Skin Cancer 2012;2012:231693 Google Scholar
6 Weinstock, MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994;171:1225–30Google Scholar
7 Ragnarsson-Olding, BK, Nilsson, PJ, Olding, LB, Nilsson, BR. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years. Acta Oncol 2009;48:125–31Google Scholar
8 McLaughlin, CC, Wu, XC, Jemal, A, Martin, HJ, Roche, LM, Chen, VW. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103:1000–7Google Scholar
9 Ragnarsson-Olding, B, Johansson, H, Rutqvist, LE, Ringborg, U. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer 1993;71:1893–7Google Scholar
10 Chang, AE, Karnell, LH, Menck, HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664–78Google Scholar
11 Chiu, NT, Weinstock, MA. Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch Otolaryngol Head Neck Surg 1996;122:985–8Google Scholar
12 Gal, TJ, Silver, N, Huang, B. Demographics and treatment trends in sinonasal mucosal melanoma. Laryngoscope 2011;121:2026–33Google Scholar
13 Manolidis, S, Donald, PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997;80:1373–86Google Scholar
14 Moreno, MA, Roberts, DB, Kupferman, ME, DeMonte, F, El-Naggar, AK, Williams, M et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center. Cancer 2010;116:2215–23Google Scholar
15 Thompson, LD, Wieneke, JA, Miettinen, M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594–611 Google Scholar
16 Neugut, AI, Kizelnik-Freilich, S, Ackerman, C. Black-white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health 1994;84:1828–9Google Scholar
17 Holmstrom, M, Lund, VJ. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med 1991;48:9–11 Google Scholar
18 Mackintosh, JA. The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol 2001;211:101–13Google Scholar
19 Maldonado, JL, Fridlyand, J, Patel, H, Jain, AN, Busam, K, Kageshita, T et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003;95:1878–90Google Scholar
20 Beadling, C, Jacobson-Dunlop, E, Hodi, FS, Le, C, Warrick, A, Patterson, J et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008;14:6821–8Google Scholar
21 Curtin, JA, Busam, K, Pinkel, D, Bastian, BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24:4340–6Google Scholar